IndraLab

Statements

USP29 deubiquitinates MAP3K7. 3 / 3
| 3
reach
"Mechanistically, USP29 reduces the sterile inflammation and hepatocellular damage by deubiquitinating TAK1 and preventing its phosphorylation, thereby suppressing the activation of its downstream JNK/p38 pathways."
37304282
reach
"As we expected, USP29 significantly reduced the level of ubiquitination of the TAK1 level (Figure 7E)."
37304282
reach
"As we expected, USP29 significantly decreased the level of ubiquitination of TAK1 after interacting with TAK1."
37304282